Orchid Pharma Ltd

BSE: 524372

36

total announcements

524372.BO · 15 min delayed

BSEOthersMgmt Change3 Sept 2026

Orchid Pharma Ltd

Outcome of Board meeting.

Orchid Pharma Ltd has announced the outcome of its Board meeting, where it has approved the appointment of a new Whole-Time Director, Mr. Arjun Dhanuka, and the appointment of a new Cost Auditor for FY 2026-27. The company has also scheduled its 33rd Annual General Meeting for September 29, 2026.

Read more →📎 1 attachment
BSECompany Update▼ NegativeResults24 Aug 2026

Orchid Pharma Ltd

Transcript of Analysts/Investors earning call held with public at large on August 21, 2026.

Orchid Pharma Ltd's Q1 FY27 earnings conference call was held on August 21, 2026, with senior management discussing the company's financial performance for the quarter ended June 30, 2026. The call highlighted the challenges faced by the cephalosporin business, with revenue from operations at INR1,233 crores, a decline from INR1,398 crores in FY25. Gross margin moderated by approximately 4% to 32% in FY26 compared to 36% in FY25. The management remains disciplined on controllable costs.

Read more →📎 1 attachment
BSECompany UpdateResults14 Aug 2026

Orchid Pharma Ltd

Statement of Deviation or variation for the quarter ended June 30, 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.

Orchid Pharma Ltd has filed a statement of deviation or variation for the quarter ended June 30, 2026, on the use of proceeds of funds raised through Qualified Institutional Placement (QIP). The company has modified the allocation of QIP proceeds due to changes in the business environment and to meet current strategic requirements.

Read more →📎 1 attachment
BSEBoard MeetingM&A1 Aug 2026

Orchid Pharma Ltd

Outcome of Board Meeting held on August 01, 2026

Orchid Pharma Ltd has informed that its Board of Directors has approved the issuance and allotment of 4,45,86,052 fully paid-up equity shares to eligible shareholders of Dhanuka Laboratories Ltd as part of the scheme of amalgamation. The shares will be listed and traded on BSE and NSE and will rank pari-passu with existing equity shares.

Read more →📎 1 attachment
BSECompany Update25 Jul 2026

Orchid Pharma Ltd

Intimation regarding Investor Roadshow

Orchid Pharma Ltd has announced an Investor Roadshow scheduled to be held in Singapore on July 29-31, 2026. The event will be attended by Mr. Mridul Dhanuka, Whole Time Director of the Company. No unpublished price sensitive information will be shared during the meet.

Read more →📎 1 attachment
← PreviousPage 2 of 2